To explore the safety and feasibility of intra-arterial neuroprotective strategy in acute ischemic stroke patients who missed recanalization operation.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Intra-arterial administration of 3-n-butylphthalide for 24 hours via microcatheter at 17.36 ug/min.
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China
RECRUITINGProportion of server adverse events
server adverse events including femoral artery dissection, local thrombosis, seudoaneurysm, arteriovenousfistula, etc.
Time frame: 48 hours
Proportion of patients with modified Rankin Score 0 to 1
Proportion of patients with modified Rankin Score 0 to 1
Time frame: 90 days
Proportion of patients with modified Rankin Score 0 to 2
Proportion of patients with modified Rankin Score 0 to 2
Time frame: 90 days
Modified Rankin Score
Modified Rankin Score
Time frame: 90 days
Decrease in national institutes of health stroke scale (NIHSS)
Decrease in NIHSS scoring at 48 hours after the treatment
Time frame: 48 hours
Proportion of symptomatic intracranial hemorrhage (sICH)
sICH was defined as 4 or more increase in NIHSS caused by hemorrhage
Time frame: 48 hours
Proportion of intraparenchymal hemorrhage (PH1 and PH2)
Proportion of intraparenchymal hemorrhage (PH1 and PH2) within 48 hours after the treatment
Time frame: 48 hours
Changes in cerebral edema
Cerebral edema was determined by cerebral volume or midline shift
Time frame: 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
All causes of death within 48 hours after the treatment
All causes of death within 48 hours after the treatment
Time frame: 48 hours
Differences in serum factors levels in different artery region
Differences in serum factors levels in different Bessel region before recanalization
Time frame: 0 hour